Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Genmab
Genmab
Fate Therapeutics
Center for International Blood and Marrow Transplant Research
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Allogene Therapeutics
Dartmouth-Hitchcock Medical Center
Dana-Farber Cancer Institute
Center for International Blood and Marrow Transplant Research
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
City of Hope Medical Center
Sana Biotechnology
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
City of Hope Medical Center